CUSIP 68062P106COMOLMAQ4 2025
50 filings · latest Mar 6, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bain Capital Life Sciences Investors, LLC | 8.51M | $212.72M |
| 2 | Paradigm Biocapital Advisors LP | 7.54M | $188.60M |
| 3 | Janus Henderson Group PLC | 6.71M | $167.90M |
| 4 | Blackrock, Inc. | 5.56M | $139.08M |
| 5 | Bvf Inc/Il | 5.30M | $132.40M |
| 6 | Fmr LLC | 5.02M | $125.58M |
| 7 | Vanguard Group Inc | 3.56M | $89.03M |
| 8 | Siren, L.L.C. | 3.30M | $82.52M |
| 9 |
| 4 | Feb 13, 2026 | Deep Track Capital, LP | 13G/A | — | — | SEC |
| 5 | Feb 5, 2026 | Fmr LLC | 13G | 6.3% | 5.02M | SEC |
| 6 | Nov 14, 2025 | Janus Henderson Group PLC | 13G | 5.2% | 3.59M | SEC |
| 7 | May 15, 2025 | Deep Track Capital, LP | 13G/A | 5.0% | 3.44M | SEC |
| 8 | May 15, 2025 | Bain Capital Life Sciences Opportunities IV, L.P. | 13G/A | 10.0% | 6.84M | SEC |
| 9 | May 15, 2025 | Point72 Asset Management, L.P. | 13G/A | 2.3% | 1.54M | SEC |
| 10 | May 13, 2025 | Logos Global Management LP | 13D/A | 4.7% | — | SEC |
See the full Schedule 13D/13G history for Olema Pharmaceuticals Inc.
Unlock full history| 3.21M |
| $80.22M |
| 10 | Cormorant Asset Management, LP | 2.75M | $68.75M |